Aigen Investment Management LP Makes New Investment in Marsh & McLennan Companies, Inc. $MRSH

Key Points

• Aigen Investment Management initiated a new position in Marsh & McLennan Companies, buying 17,425 shares worth about $3.23 million in the fourth quarter. The stock now ranks as Aigen’s 19th largest holding.
• Institutional interest remains high, with several other funds also increasing their stakes; overall, about 87.99% of MRSH shares are owned by institutional investors. Meanwhile, CEO John Q. Doyle sold 16,656 shares in a pre-arranged Rule 10b5-1 transaction.
• Marsh & McLennan reported solid quarterly results, posting EPS of $3.29 versus the $3.21 estimate and revenue of $7.30 billion, up 7.6% year over year. Analysts currently have a consensus Hold rating with an average price target of $200.19.

Aigen Investment Management LP bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 17,425 shares of the financial services provider's stock, valued at approximately $3,233,000. Marsh & McLennan Companies makes up about 0.8% of Aigen Investment Management LP's portfolio, making the stock its 19th largest holding.

Several other large investors also recently added to or reduced their stakes in the business. Numerai GP LLC raised its stake in Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock valued at $7,501,000 after purchasing an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd raised its stake in Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock valued at $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Barclays PLC raised its stake in Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock valued at $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Sarasin & Partners LLP raised its stake in shares of Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider's stock valued at $173,411,000 after buying an additional 8,283 shares in the last quarter. Finally, Brown Brothers Harriman & Co. raised its stake in shares of Marsh & McLennan Companies by 26.4% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider's stock valued at $27,444,000 after buying an additional 28,419 shares in the last quarter. 87.99% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of the firm's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company's stock.

Wall Street Analyst Weigh In

MRSH has been the subject of a number of recent research reports. Morgan Stanley dropped their price objective on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating for the company in a research note on Monday, April 6th. Barclays dropped their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating for the company in a research note on Wednesday, April 8th. Wells Fargo & Company dropped their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating for the company in a research note on Thursday, April 9th. Piper Sandler dropped their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a research note on Tuesday, May 26th. Finally, Raymond James Financial upgraded shares of Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 price objective for the company in a research note on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Marsh & McLennan Companies has an average rating of "Hold" and a consensus price target of $200.19.

Marsh & McLennan Companies Price Performance

Shares of NYSE:MRSH opened at $168.67 on Friday. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market cap of $81.49 billion, a price-to-earnings ratio of 21.08, a P/E/G ratio of 2.46 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last issued its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm's revenue was up 7.6% on a year-over-year basis. On average, sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

About Marsh & McLennan Companies

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.